ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1869

The Role of Faecal Calprotectin in IgA Vasculitis

Alojzija Hocevar1, Matija Bajzelj1, Matija Tomšič2 and Katja Lakota3, 1UKC Ljubjana, Ljubjana, Slovenia, 2Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 3Department of Rheumatology, University Medical Centre Ljubljana, Llubljana, Slovenia

Meeting: ACR Convergence 2021

Keywords: IgA vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 9, 2021

Session Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II (1862–1888)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Gastrointestinal involvement (GI) is associated with significant morbidity in acute IgA vasculitis (IgAV). Besides the abdominal pain, bowel ischemia could lead to bleeding, perforation, or ileus among others. Our aim was to investigate the role of faecal calprotectin measurement in patients with adult IgAV.

Methods: Faecal calprotectin was determined at presentation in 70 patients with histologically proven adult IgAV diagnosed at our secondary/tertiary rheumatology center. Based on the calprotectin level, patients were stratified into two groups – those with elevated vs. normal level (the cut off >50 μg/g). Clinical features of patients with elevated vs. normal faecal calprotectin were compared. Logistic regression was used to determine factors associated with elevated faecal calprotectin in IgAV.

Results: Our cohort consisted of 45 males (64.3%) and 25 females (35.7%), median (IQR) age 63.9 (45.9; 69.2) years, with median (IQR) IgAV symptom duration time 7 (4; 21) days. Seventeen patients (24.3%) had GI involvement (abdominal pain, overt GI bleeding, occult GI bleeding, diarrhoea, ileus developed in 15, 4, 12, 6 and 1 patient, respectively). Twenty-eight out of 70 patients (40.0%) had elevated faecal calprotectin, with median (IQR) level of 86.3 (64.0; 192.8) μg/g, of them 8 had clinically GI involvement. We found no significant association between clinical GI involvement and elevated faecal calprotectin (p=0.574). Characteristics of IgAV patients with elevated vs. normal faecal calprotectin are presented in Table 1. Multivariate analysis showed that elevated calprotectin was associated with increasing patient age (OR 1.04 (95%CI 1.01-1.08); p=0.018), purpura above waistline (OR 3.37 (95%CI 1.07-10.58); p=0.037) and C-reactive protein (OR 1.02 (95%CI 1.00-1.03); p=0.017

Conclusion: Our result show that the role of faecal calprotectin measurements in evaluating GI involvement adult IgAV is rather limited.

Table 1. Characteristics of IgA vasculitis patients with elevated vs. normal fecal calprotectin


Disclosures: A. Hocevar, None; M. Bajzelj, None; M. Tomšič, None; K. Lakota, None.

To cite this abstract in AMA style:

Hocevar A, Bajzelj M, Tomšič M, Lakota K. The Role of Faecal Calprotectin in IgA Vasculitis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-role-of-faecal-calprotectin-in-iga-vasculitis/. Accessed February 3, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-faecal-calprotectin-in-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences